-Reuters
Gamida Cell Announces Pricing Of $22.8M Public Offering Of 17.5M Shares Of Common Stock And Warrants At A Price Of $1.30/Share And Exercise price of $1.35/Warrant
Gamida Cell Ltd. (NASDAQ:GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the pricing of an underwritten public offering of 17,500,000 ordinary shares and accompanying